Medicare Part D Plans Can Be Sponsored By Joint Enterprises, CMS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The corporate structure will allow plans operating in one state to sponsor a prescription drug benefit in multi-state regions without obtaining licenses in the other states. CMS will require a joint enterprise to enter a single contract, submit a single bid and market the plan under a single name.
You may also be interested in...
Medicare Rx Plan Candidates Down To The Wire: Applications Due March 23
CMS will accept applications from Part D prescription drug plans, Medicare Advantage drug benefit providers and cost contractors. Related reporting requirements are scheduled to be posted on CMS’ website in April.
Natrecor Use Should Be Limited, Independent Panel Convened By J&J Says
The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.
CMS Has “Very Robust” Number Of Medicare Part D Bids, McClellan Says
Following the June 6 bid submission deadline, CMS expects to have multiple drug plans in every region. Administrator McClellan declines to provide exact number of Part D bids.